BLFS: BioLife O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati

BioLife Solutions, Inc. (BLFS) tovar belgisi

GURU.Markets aniqlik servisining ushbu PEG grafigi BioLife Solutions, Inc. (BLFS) kompaniyasining o'sish potentsialini baholash imkonini beradi, bunda 0.00 qiymati joriy ko'rsatkichni anglatadi. BioLife Solutions, Inc. (BLFS) AQSHda yuqori texnologiyali zavodlarni boshqaradi va kriokonservatsiya muhitlarining barqaror yetkazib berilishini ta'minlaydi. Kompaniyaga tegishli ekologik rivojlanish vektori qayta ishlanadigan qadoqlarni joriy etishni nazarda tutadi, sarf materiallariga bo'lgan barqaror talab esa muntazam pul oqimini kafolatlaydi.

BioLife Solutions, Inc. (BLFS) - PEG multiplikatori 04.07.2022dan 18.10.2026gacha

BioLife Solutions, Inc. (BLFS) kompaniyasi koʻrsatkichlari kesimi va tahlili

- joriy narx va aksiyalarning prognoz qilingan qiymati:
- bozor kapitallashuvi haqida ma'lumot:
Kompaniyaning fundamental tahlili:BLFS - BioLife Solutions Inc
BioLife Solutions tayyor mahsulotlari

BioLife Solutions, Inc. (BLFS) kompaniyasining narxlarni belgilash kuchi, uning sarf materiallarining sog'liqni saqlash gigantlarining texnik jarayonlariga integratsiyalashuviga asoslangan holda, foydani kengaytirish uchun barqaror salohiyat yaratadi. P/E ko'rsatkichini ushbu o'sish sur'atlari bilan solishtirish, ko'rsatkichlar birdan pastga tushganda, o'sishga moslashtirilgan P/E nisbati orqali fundamental aktivlarning qadrini past baholashni aniqlash imkonini beradi va bu "raketa"ning haqiqiy salohiyatini kapital stagnatsiyasi xavflaridan ajratib ko'rsatadi.

BioLife Solutions, Inc. raqobatchilari

Narxning foydaga va o‘sish sur’atiga nisbati TEM (Tempus AI, Inc)|PEG multiplikatori QGEN (Qiagen Group)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Isis Pharmaceuticals (IONS)|Repligen Corporation - PEG multiplikatori|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati RNA|CRSP: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda GeneDx Holdings (WGS)|Narx-foyda va o‘sish multiplikatori RARE|BEAM: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Sarepta Therapeutics, Inc. (SRPT)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati twistbioscience.com|Narxning foydaga va o‘sish sur’atiga nisbati 10x Genomics TXG|Intellia Therapeutics Inc (NTLA) - O‘sish sur’atiga tuzatilgan narx-foyda|STOK - Narxning foydaga va o‘sish sur’atiga nisbati|WVE: Narxning foydaga va o‘sish sur’atiga nisbati|MAZE (Maze Therapeutics Inc) - Narx-foyda va o‘sish multiplikatori|sionnatx.com (SION) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori PRME|TSHA (Taysha Gene Therapies Inc) - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|PEG multiplikatori QURE|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati MeiraGTx Corp|Narxning foydaga va o‘sish sur’atiga nisbati REGENXBIO Inc. RGNX|solidbio.com (SLDB) - O‘sish sur’atiga tuzatilgan narx-foyda|OCGN - Narxning foydaga va o‘sish sur’atiga nisbati|PACB (Pacific Biosciences of California, Inc.) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Benitec (BNTC) - Narxning foydaga va o‘sish sur’atiga nisbati|DSGN - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narx-foyda va o‘sish multiplikatori RCKT|FDMT: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori LXEO|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati korrobio.com|Narxning foydaga va o‘sish sur’atiga nisbati Editas EDIT|SLN: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|ProQR Therapeutics NV - PEG multiplikatori|Codexis, Inc. (CDXS) - Narx-foyda va o‘sish multiplikatori|SGMO (Sangamo Therapeutics, Inc.) - Narx-foyda va o‘sish multiplikatori|NAUT - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|MGX (Metagenomi, Inc) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati DTIL|Narxning foydaga va o‘sish sur’atiga nisbati Generation Bio Co. (GBIO)|Narxning foydaga va o‘sish sur’atiga nisbati BOLD (boundlessbio.com)|PEG multiplikatori XCUR (Exicure)|IMNN (Imunon Inc) - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|PHIO - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Mustang Bio, Inc. MBIO|RNAZ: PEG multiplikatori|O‘sishni hisobga olgan narx-foyda koeffitsiyenti BNGO|Narxning foydaga va o‘sish sur’atiga nisbati Applied DNA Sciences, Inc.|O‘sishni hisobga olgan narx-foyda koeffitsiyenti BLUE (bluebird bio Inc.)|PEG multiplikatori IPA|PEG multiplikatori Omega Therapeutics Corp (OMGA)|PEG multiplikatori OMIC (Singular Genomics Systems)|regulusrx.com - Narxning foydaga va o‘sish sur’atiga nisbati|Syros Pharmaceuticals, Inc. - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Telesis Bio Inc. TBIO|TRACON (TCON) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda Unity Biotechnology, Inc (UBX)